13:16 IST
BSE
Other Announcement
Aptus Pharma Other Announcement
Aptus Pharma Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulatory requirements.
Aptus Pharma Ltd
- Share price
- ₹385.20
- Market cap
- ₹660.6 Cr
- Revenue (annual)
- ₹46.57 Cr
- Net profit (annual)
- ₹4.62 Cr
- P/E (TTM)
- 143.0×Sector 47.3×
- Promoter holding
- 72.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Promoter Buying (Off-Market) 4Fund Raise 3Board Meeting Outcome 3Other Announcement 2Financial Results 2Capital Structure Change 2Board Meeting Date 2Annual General Meeting 2Results Update 1Promoter Selling (Off-Market) 1Earnings Call 1Credit Rating 1Capacity Expansion 1Annual Report 1
Time
2 announcements with these filters
20:02 IST
BSE
Other Announcement
Aptus Pharma Other Announcement
Aptus Pharma Ltd informed BSE that Regulation 24A of SEBI (LODR) Regulations, 2015, regarding the Annual Secretarial Compliance Report, is not applicable to the company. As an entity listed on the SME Exchange, it falls under the exemptions provided in Regulation 15(2)(b).